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Abstract: The increasing prevalence of antibiotic-resistant strains of bacteria has led to a crisis in treatment 
options. Acinetobacter baumannii is an example of a bacterium that has developed a dangerous level of multidrug 
resistance. Not only does it have genes allowing for the resistance to antibiotics, but it also produces a biofilm that 
protects it. In recent years, A. baumannii has become a major contributor to nosocomial infections making it critical 
to develop new treatment methods. Micrococcus luteus, while typically not thought of as a pathogen, is also 
developing a resistance to antibiotics. M. luteus is capable of forming a biofilm on its own making it worrisome as it 
has increasingly been noted as an opportunistic pathogen.  
One potential new treatment of antibiotic resistance is the development of bacteriophage therapy, using bacterial 
viruses to target the infection and treat it. This study examines methods for isolating novel bacteriophage from dairy 
cattle feces, specifically for the biofilm producers A. baumannii and M. luteus. 
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1. Introduction 
 
One of the rising concerns within the medical 
health profession is the increase in cases of multidrug-
resistant Bacteria. Multidrug-resistant organisms 
(MDROs) exhibit resistance to more than one 
antibiotic, leading to difficulties in finding treatment 
that is effective. One Gram-negative bacterium that is 
of huge concern is Acinetobacter baumannii, in which 
some strains are showing resistance to all available 
antibiotic agents [1]. 
A. baumannii is a Gram-negative, aerobic, non-
fermentative, coccobacillus bacterium that is considered 
ubiquitous and can survive very harsh environments, 
including surfaces in healthcare facilities [2-5]. This is 
problematic because of the growing antibiotic 
resistance co-occurring with this organism [3,6-9]. A. 
baumannii has been categorized as an opportunistic 
pathogen but in the past few years, it has caused many 
infections in both immunocompromised and healthy 
individuals [6,7,10]. It is responsible for hospital-
acquired (nosocomial) pneumonia, urinary tract 
infections (UTI), bloodstream infections, and wound 
infections [11-14]. The ability of A. baumannii to 
become drug resistant has led to its classification as a 
‘critical’ organism by the WHO [7].  
Biofilms likely play a role in the ability of A. 
baumannii to survive long periods of time in 
environments that lack moisture, or even in the 
presence of disinfectants. This allows the organism to 
cling to and survive on otherwise sterile surfaces, as in 
clinical environments [6]. Biofilms are one of the major 
factors determining whether antibacterial treatments 
fail, along with genes the bacteria contain. It is hard for 
antibiotics to get through the thick polysaccharide 
matrix of the biofilm and make it to the bacterial cells 
[8,15-19].  
Biofilms have been associated with infections 
causing endocarditis, UTI, chronic otitis media, chronic 
bacterial prostatitis, and respiratory tract infections seen 
with cystic fibrosis patients [6]. In some instances, the 
organisms capable of forming biofilm that may cause 
infections from medical equipment may be normal flora 
of the skin, oral cavity, urinary tract, reproductive 
system, and gastrointestinal tract [6,16]. This is the case 
in the instances of infection by Micrococcus luteus. 
Micrococcus luteus has been designated normal 
flora of the oral cavity. It is a gram-positive bacterium 
that group in tetrads [20,21]. Like A. baumannii, M. 
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luteus is ubiquitous in the environment, however, it is 
rarely the source of disease. Because of the 
classification as normal flora, it is often considered a 
contaminate when seen in cultured specimens. This can 
delay treatment in instances where M. luteus is the 
opportunistic pathogen and the source of the infection. 
As a pathogen M. luteus has typically been seen in 
cases of immunocompromised individuals, however, it 
is increasingly being seen in relation to biomedical 
procedures [22]. It has been associated with septic 
arthritis, meningitis, endocarditis, intracranial 
abscesses, and pneumonia [21,23]. Typically, these 
infections have been traced back to medical equipment 
such as indwelling intravenous lines, continuous 
ambulatory peritoneal dialysis fluids, ventricular 
shunts, and prosthetic valves [21,22].  
M. luteus has several ways of avoiding antibiotics 
even though there have rarely been associated with 
antibiotic resistance. One way, which is like A. 
baumannii, is its ability to form a biofilm. A second and 
more unique method is dormancy. The cells of M. 
luteus can decrease their metabolism in order to survive 
conditions that would be otherwise fatal to the cells 
[24]. These cells can survive three to six months in this 
dormant state and still return to an active metabolic 
state and begin to divide to increase the population [20]. 
This dormant behavior prevents most antibiotics from 
acting on the organism [25]. Without actively dividing 
cells antibiotics that target peptidoglycan production are 
ineffective, and without normal metabolic processes 
occurring antibiotics that target metabolism also fail to 
work [24,25].  
Recently there has been interest in looking at 
bacteriophage as a new method of treatment for these 
harder to treat infections [6,11,16,26-30]. 
Bacteriophage was discovered in 1896 by and were first 
described for their antibiotic properties [16,30]. Phage 
are viruses that specifically target and lyse bacterial 
cells. They can be isolated from nearly everywhere sea 
water, sewage water, sludge pods, feces, food, etc. and 
they typically utilize the bacteria that are already 
present in the sample as their hosts [27].  Bacteriophage 
presents a new form of treatment because of their 
ability to multiply exponentially, their mode of action, 
the ability to move through protective biofilms, and 
their selective nature [6,11,16,26-30].  
Because phage only targets specific bacterial 
species or even specific strains, they are more likely to 
be safe for use on plants and animals [2]. Their ability 
to filter through biofilms implies that they can function 
in conditions where antibiotics are unable to reach 
[6,11,26]. Phage injects their genetic material into 
bacterial cells, including dormant cells, and hijack the 
cells own mechanics to replicate the phage particles. 
This is completely different than the mode of action of 
antibiotics and means that they can be used against 
multidrug-resistant strains of bacteria [3,6,11,16,26,30]. 
This study looks at three slightly varying methods 
of isolating lytic bacteriophage for A. baumannii ATCC 
19606 and M. luteus. These bacteria were chosen 
because of their ubiquitous nature and their ability to 
form biofilms. Dairy cattle feces was utilized as the 
source to look for novel bacteriophage, due to the 
ubiquitous nature of these bacteria and the fact that 
dairy cattle feces has not readily been studied for 
bacteriophage isolation, yet the close interaction of 
these animals with human pathogens has. The feces 
may be a good source for possible bacteriophage for A. 
baumannii, M. luteus. 
 
2. Material and Methods 
 
2.1.  Method 1: One-week incubation 
The first method utilized to isolate bacteriophage 
involved two separate week-long incubations. 5 grams 
of dairy cattle feces was added to 50 mL of Luria-
Bertani (LB) broth. The broth contained 10mM of 
CaCl2, which facilitates phage attachment [27]. 1 mL of 
a turbid A. baumannii or M. luteus culture was added to 
the feces and LB broth. The A. baumannii culture was 
grown overnight M. luteus was grown for 24-36 hours 
as it had a slower growth rate than A. baumannii and 
thus took longer to get to a turbid culture. These 
cultures were grown for a week to allow phage to 
interact with the bacterial cells and replicate within 
them. The A. baumannii and feces culture was 
incubated at 37˚C for the week, whereas the M. luteus 
and feces culture was incubated at room temperature 
(RT) for the week, due to their varying growth 
conditions.  
After the week incubation, the cultures were 
centrifuged at 10,000 rpm for 5 minutes. The 
supernatants were then filtered through a .45 µm filter 
and again through a .22 µm filter to ensure that no 
bacteria would be present in the phage enrichment 
solution. 1 mL of the enrichment was added to fresh 
50mL of LB, CaCl2 along with 1 mL of fresh pathogen 
culture (grown the same as previous). These cultures 
incubated for another week in the same conditions as 
they were in the first round of incubation. 
Once the incubation was complete the cultures 
were once again centrifuged and then the supernatant 
was filtered in the same manner as the previous 
incubation. The second-round enrichment was then 
combined with fresh pathogen and plated in an overlay 
method. This involves mixing 300 µL of enrichment 
with 300 µL of pathogen in 2.5 mL of soft agar (.5% 
agar instead of 2%). This solution was then poured on 
LB, 10mM CaCl2 thick poured agar plates. The liquid 
was gently swirled until the entire surface of the plate 
was covered. The plates were left undisturbed on a flat 
surface for an hour to allow the soft agar to solidify 
before they were moved for incubation. The plates 
containing the A. baumannii plus enrichment were 
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incubated overnight at 37˚C while the M. luteus plus 
enrichment plates were incubated for 36 hours at RT. 
Once the bacterial lawns had grown the plates were 
examined for clearings in the lawn. When symmetric 
clearings are formed by virus particles they are referred 
to as plaques. If plaques are present they can be utilized 
for further isolation of the phage, by two different 
methods to be discussed later.  
Controls were done using 300 µL of sterile water 
with 300 µL of pathogen in 2.5 mL of soft agar. No 
plaques should be seen on the control plates, only 
smooth bacterial lawns. 
 
2.2.  Method 2: Overnight incubation 
The second method used to isolate bacteriophage 
was done very similarly to the first. The main 
difference being that instead of each incubation being 
done for a week, they were only allowed to incubate for 
12-48 hours depending on the pathogen. The same 
measurements of broth, feces, and pathogen that were 
used in the initial incubation were used in this 
experiment. The solutions were filtered the same 
between each step and the final enrichment was plated 
in the same soft agar overlay method. The plates were 
incubated the same as in the first method, and each 
plate was again examined for plaque formation. 
Controls were also done in the same manner as in the 
previous method. 
 
2.3. Method 3: Overnight incubation without 
pathogen 
The third method utilized for phage isolation 
changed a little bit more from the first two. Due to the 
large quantity of left over enrichment the measurements 
were decreased for the incubating samples. The 
measurements instead were 5 mL of broth inoculated 
with .5 g of feces that were left to incubate overnight. 
There was no addition of pathogen in the initial 
incubation. The following day the enrichments were 
centrifuged and filtered as before then used in the 
second incubation. 5 mL of broth were combined with 
100 µL of turbid pathogen culture and 100 µL of 
enrichment. The cultures were incubated in the same 
fashion as the first two methods before being 
centrifuged, filtered, and plated.  
Control plates were done in the same fashion as the 
previous two methods.  
 
2.4.  Phage Isolation 
When plaques are seen on the plates they need to 
be further isolated to ensure that a single phage is 
present in an isolated culture. Because the initial 
enrichment came from a mixed culture it is possible 
that there may be more than one phage present on the 
plates. This is done in one of two ways; the first is to 
core a selection of isolated plaques. Typically, this 
procedure is done with at least 5 separate plaques. The 
extraction was done by extracting a 1 mm diameter 
section of plate that contains a single plaque, using a 
pasture pipette for ease of transfer. This agar piece was 
placed in 1 mL fresh LB, 10mM CaCl2 and placed in a 
4˚C refrigerator overnight to allow the phage to elute 
out of the agar and into the broth without allowing for 
bacterial growth. The next day the solutions were plated 
using the soft agar overlay method. After an overnight 
incubation, the plates were examined for plaques. 
The second method of phage isolation was done 
when the plaques are too close together to be extracted 
individually using the pipette method. Instead, an 
overlay of 10 mL of LB, 10mM CaCl2 broth was added 
to the top of the soft agar plates and they were left on a 
flat surface overnight. The overnight incubation at RT 
acts in the same manner as the 4˚C incubation, it 
allowed for the phage to elute out of the agar and into 
the broth. The broth was then centrifuged and filtered 
given that bacterial cells can grow at RT. The sample 
was then diluted from 101 to 1010 and plated in the soft 
agar overlay method and incubated overnight. The 
plates were then examined for plaque formation. 
 
3. Results  
 
3.1.  Control plates 
Growth on the control plates was typically a 
uniform bacterial lawn showing few if any 
deformations of the agar (Fig. 1). There was an issue 
with some of the A. baumannii control plates in that 
they showed a swirl pattern characteristic of biofilm 
formation. Within the swirls, clearings could be seen 
that were similar to plaque formations, but this did not 
occur on every control plate (Fig. 2). M. luteus control 
plates all showed the same uniform bacterial lawn 
growth across the soft agar surface. 
 
3.2. One-week incubation 
The plates made from the enrichments that were 
left to incubate for a weeks’ time showed no visible 
plaques. Each plate, for both A. baumannii and M. 
luteus, showed uniform bacterial lawns that looked no 
different than the control plates. 
 
3.3.  Overnight incubation 
The plates made from the enrichments that were 
left to incubate overnight showed plaque like clearings 
on the A. baumannii plates (Fig. 3). No plaque like 
clearings were seen on the M. luteus plates, and a weak 
lawn was noted after 18 hours. Plates were looked at 
again at 36 hours. They showed a much thicker and 
uniform lawn but no plaque-like clearings were noted. 
 
3.4.  Overnight incubation without pathogen 
The plates made from the enrichment that lacked 
pathogen in the first round showed plaque-like clearing 
zones for both A. baumannii and M. luteus. The M. 
luteus plates were left to grow for 36 hours to show 
adequate thickness of the lawn. The plates showed 5-10 
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plaque-like clearings per plate (Fig. 4), plaques were 
cored from one plate and a broth overlay was 
performed on another.  
 
3.5.  Plaque Isolation 
Because of the issue seen with the A. baumannii 
control plates neither coring or broth overlay were 
completed with these samples. The cored samples for 
M. luteus showed few possible plaque-like clearings, 
but the broth overlay dilutions showed a great reduction 
in bacterial growth (Fig. 5,6). Bacterial cell density was 
taken from the same turbid culture in the same 
measurements across all 10 dilution plates. The 1010 
dilution showed not only a reduction in bacterial growth 
but plaque-like clearings as well (Fig. 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Photograph of a control plate for M. luteus after 36 hours incubation at RT, showing a uniform bacterial lawn. 
 
 
 
Fig. 2. Picture of a control plate for A. baumannii after 18-hour incubation at 37˚C, showing the swirl pattern containing plaque-like 
clearings. 
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Fig. 3. Photographs of soft agar overlay plates for A. baumannii after 18-hour incubation at 37˚C, showing scattered clearings consistent 
with possible plaque formation. The large holes in the agar are from coring isolated plaques for further testing. 
 
 
 
Fig. 4. Photographs of soft agar overlay plates for M. luteus after 36-hour incubation at RT, showing cored holes with a few plaque-like 
clearings (left) and circled plaque like clearings in the agar (right). 
 
 
Fig. 5. Photographs of M. luteus broth overlay plating after 36 hours of incubation at RT, showing decreasing bacterial growth with 
increasing dilution of broth overlay stock solution. A thick lawn for the 108 dilution (left), thinner lawn for the 109 dilution (middle), thin 
lawn with plaque-like clearings for the 1010 dilution (right). 
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Fig. 6. Photograph of M. luteus broth overlay plating after 36 hours of incubation at RT, showing decreasing bacterial growth from dilution 
108 (left) to dilution 1010 (right). 
 
 
 
Fig. 7. Photograph of M. luteus broth overlay plating after 36 hours of incubation at RT, showing phage-like plaques on a light box for the 
dilution 1010 (left), and a view using a dark background (right). 
 
4. Discussion 
 
Three slightly varying methods were used to try 
and isolate novel bacteriophage from dairy cattle feces, 
with A. baumannii or M. luteus as their hosts. The first 
method of enriching showed no isolation of phage. The 
lack of any visible plaques on the plates could be from 
the conditions in the media after a weeks’ worth of 
growth. Bacteriophage are relatively delicate; they have 
a small range of pH and temperature that they remain 
viable in. Once the bacteria have reached stationary 
phase and start lysing or dying off the cellular 
components they release into the culture may reduce the 
viability of the phage in the solution.  
The extended exposure to bacterial cells also 
increases the likelihood that the cells that remain in the 
culture may have developed a resistance to the phage 
present. Bacteria have innate defense against the 
attachment or injection of the phage genome and after a 
period of time, many of the cells in the solution may be 
showing those resistance. One of the most well-known 
defense mechanisms in bacteria is the CRISPR system 
and it has been a target of study in recent years [31]. 
The resistant cells would then become the more 
prevalent cells in the culture and reduce the likelihood 
of recovering phage.  
The results of the one-week incubation lead to the 
changes to overnight incubation method. The bacterial 
cultures were still in the log phase in an overnight 
culture and thus may have actively dividing phage in 
the culture as well. The addition of the pathogen in the 
initial incubation would allow for any phage that 
utilizes the pathogen as a host to replicate in the initial 
enrichment. This was possibly seen with A. baumannii 
since plaque-like clearings were seen on the sample 
plates. However, it can’t be said for certain that this was 
the cause of phage for A. baumannii, given the plaque-
like clearings that were noted on some of the control 
plates as well.  
There is the possibility that the clearings seen on 
the control plate, and thus on the experimental plates, 
may have been caused by lysogenic phage (prophage) 
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being triggered to enter the lytic cycle of their division. 
Something within the environmental conditions of the 
incubating plates may have initiated the lysing of cells 
by phage that otherwise remains dormant within the 
bacterial genome [16,30]. 
The clearings could also be caused by the presence 
of biofilm formation in the starter culture. The 
polysaccharide polymers may cause the swirl patterns 
seen on the control plate and may block bacterial 
growth from some sections of the plate. One way to 
combat the possibility of biofilm formation in the 
starter culture causing the issues seen in the control 
plates would be to do a growth curve assay on the A. 
baumannii strain used. This would ensure that the 
starter culture was in the log phase of growth and that 
biofilm formation was at a minimum. This was the 
suspected cause of the issues with phage isolation for A. 
baumannii in this study as the appearance of the swirl 
patterns and clearings were only seen periodically on 
the control plates.  
Another way to verify that what was seen on the 
experimental plates may have been phage is for a spot 
test to be performed. A spot test is done by creating a 
bacterial lawn on a plate using soft agar containing the 
pathogen that has been allowed to solidify. The phage 
enrichment samples are then spotted onto the soft agar 
surface in increasing dilutions. Once dry the plates are 
incubated and then examined for clearings that reduce 
with each dilution [32]. 
These swirl patterns were not seen with M. luteus, 
but neither were any plaque-like clearings. Further 
adjustments to the methods were then done to facilitate 
a larger number of possible phage in the enrichment. 
Instead of adding pathogen to the first incubation the 
feces was incubated overnight on its own. This 
increased the likelihood of the phage present in the 
sample would be amplified before pathogen was added 
to it. The second incubation included the pathogen to 
further amplify any phage that were present that could 
use it as a host. It was with this method that plaque-like 
clearings were seen with M. luteus.  
Single phage cores were taken and re-plated from 
these initial samples and the initial results were 
inconclusive, showing plaque-like clearings but not in 
the increased number that was expected or showing no 
plaques at all. It is possible that the diffused phage 
number was too high in these samples, as they were not 
diluted out and re-plated. Diluting the cored samples 
and plating may offer more conclusive results.  
Broth overlays were also done on the initial 
samples and the serial dilutions of the broth overlay 
showed a reduction in growth of the bacterial lawn. The 
1010 dilution also showed an abundant number of small 
plaque-like clearing zones. While these results do not 
conclusively indicate that phage has been isolated for 
M. luteus they do make a strong suggestion that this is 
the case. Further dilution of the broth overlay would 
need to be done to get better spacing between plaque-
like clearings so single phage coring could be done to 
ensure isolation.  
This study did not conclusively show the isolation 
of bacteriophage from both A. baumannii and M. luteus, 
but it did suggest that novel phage may be present in 
the samples. Future research needs to be done to verify 
that what was seen is in fact bacteriophage acting on the 
bacteria present, but it is reasonable to conclude that the 
methods used within this study can be used to isolate 
bacteriophage. This approach was used to look for 
novel phage from dairy cattle feces, an area that has 
previously not been looked at for novel phage, to 
identify phage that may be candidates for use in 
bacteriophage therapy. The discovery of novel 
bacteriophage is important given the sharp increase in 
MDRO being seen in both nosocomial and community-
acquired infections. New therapies offer a different way 
to combat severe infections that may otherwise kill 
patients when conventional antibiotics don’t work. 
Bacteriophage also can move through biofilms 
increasing their activity at clearing infection when 
compared to antibiotics alone. 
 
References 
 
[1]. Magiorakos, A.P., Srinivasan, A., Carey, R.B., 
Carmeli, Y., Falagas, M.E., Giske, C.G., 
Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-
Liljequist, B., Paterson, D.L., Rice, L.B., Stelling, 
J., Struelens, M.J., Vatopoulos, A., Weber, J.T., 
Monnet, D.L. (2012). Multidrug-resistant, 
extensively drug-resistant and pandrug-resistant 
bacteria: an international expert proposal for 
interim standard definitions for acquired 
resistance. Clinical Microbiology and Infection, 
18:268-281. 
[2]. Peng, F., Mi, Z., Huang, Y., Yuan, X., Niu, W., 
Wang, Y., Hua, Y., Fan, H., Bai, C., Tong, Y. 
(2014). Characterization, sequencing and 
comparative genomic analysis of vB_AbaM-IME-
AB2, a novel lytic bacteriophage that infects 
multidrug-resistant Acinetobacter baumannii 
clinical isolates. BioMed Central Microbiology, 
181(14):1-14. 
[3]. Jin, J., Li, Z.J., Wang, S.W., Wang, S.M., Huang, 
D.H., Li, Y.H., Ma, Y.Y., Wang, J., Liu, F., Chen, 
X.D., Li, G.X., Wang, X.T., Wang, Z.Q., Zhao, 
G.Q. (2012). Isolation and characterization of 
ZZ1, a novel lytic phage that infects 
Acinetobacter baumannii clinical isolates. BioMed 
Central Microbiology, 156(12):1-8. 
[4]. Chang, K.C., Lin, N.T., Hu, A., Lin, Y.S., Chen, 
L.K., Lai, M.J. (2011). Genomic analysis of 
bacteriophage ϕAB1, a ϕKMV-like virus infecting 
multidrug-resistant Acinetobacter baumannii. 
Genomics, 97:249-255. 
[5]. Chen, L.K., Liu, Y.L., Hu, A., Chang, K.C., Lin, 
N.T., Lai, M.J., Tseng, C.C. (2013). Potential of 
Isolation of phage for Pathogenic Bacteria            Hillis et al 
J Adv Lab Res Biol (E-ISSN: 0976-7614) - Volume 9│Issue 4│2018          Page | 93 
bacteriophage ϕAB2 as an environmental 
biocontrol agent for the control of multidrug-
resistant Acinetobacter baumannii. BioMed 
Central Microbiology, 154(13):1-10. 
[6]. Yele, A.B., Thawal, N.D., Sahu, P.K., Chopade, 
B.A. (2012). Novel lytic bacteriophage AB7-
IBB1 of Acinetobacter baumannii: isolation, 
characterization and its effect on biofilm. Archives 
Virology, 157:1441-1450. 
[7]. Malaka De Silva, P., Kumar, A. (2017). Effect of 
Sodium Chloride on Surface-Associated Motility 
of Acinetobacter baumannii and the Role of 
AdeRS Two-Component System. Journal of 
Membrane Biology, 251:5-13. 
[8]. Bardbari, A.M., Arabestani, M.R., Karami, M., 
Keramat, F., Aghazadeh, H., Alikhani, M.Y., 
Bagheri, K.P. (2018). Highly synergistic activity 
of melittin with imipenem and colistin in biofilm 
inhibition against multidrug-resistant strong 
biofilm producer strains of Acinetobacter 
baumannii. European Journal of Clinical 
Microbiology & Infectious Diseases, 37:443-454. 
[9]. Bouvet, P.J.M., JeanJean, S., Vieu, J.F., 
Dijkshoorn, L. (1990). Species, Biotype, and 
Bacteriophage Type determinations compared 
with cell envelope protein profiles for typing 
Acinetobacter Strains. Journal of Clinical 
Microbiology, 28(2):170-176. 
[10]. Farmer, N.G., Wood, T.L., Chamakura, K.R., 
Everett, G.F.K. (2013). Complete Genome of 
Acinetobacter baumannii N4-Like Podophage 
Presley. Genome Announcements, 1(6):1-2.  
[11]. Dubrovin, E.V., Popova, A.V., Kraevskiy, S.V., 
Ignatov, S.G., Ignatyuk, T.E., Yaminsky, I.V., 
Volozhantsev, N.V. (2012). Atomic Force 
Microscopy Analysis of the Acinetobacter 
baumannii Bacteriophage AP22 Lytic Cycle. 
PLOS One, 7(10):1-9. 
[12]. Sato, Y., Unno, Y., Ubagai, T., Ono, Y. (2018). 
Sub-minimum inhibitory concentrations of 
colistin and polymyxin B promote Acinetobacter 
baumannii biofilm formation. PLOS One. March 
19, 2018: 1-18. 
[13]. Tiwari, V., Patel, V., Tiwari, M. (2018). In-silico 
screening and experimental validation reveal L-
Adrenaline as anti-biofilm molecule against 
biofilm-associated protein (Bap) producing 
Acinetobacter baumannii. International Journal 
of Biological Macromolecules, 107:1242-1252. 
[14]. Jeon, J., Kim, J.W., Yong, D., Lee, K., Chong, Y. 
(2012). Complete Genome Sequence of the 
Podoviral Bacteriophage YMC/09/02/B1251 
ABA BP, Which Causes the Lysis of an OXA-23-
Producing Carbapenem-Resistant Acinetobacter 
baumannii isolate from a Septic Patient. Journal 
of Virology, 86(22):12437-12438. 
[15]. Feng, J., Liu, B., Xu, J., Wang, Q., Huang, L., Ou, 
W., Gu, J., Wu, J., Li, S., Zhuo, C., Zhou, Y. 
(2018). In vitro effects of N-acetylcysteine alone 
and combined with tigecycline on planktonic cells 
and biofilms of Acinetobacter baumannii. Journal 
of Thoracic Disease, 10(1):212-218. 
[16]. Parasion, S., Kwiatek, M., Gryko, R., Mizak, L., 
Malm, A. (2014). Bacteriophages as an 
Alternative Strategy for Fighting Biofilm 
Development. Polish Journal of Microbiology, 
63(2):137-145. 
[17]. Hughes, K.A., Sutherland, I.W., Jones, M.V. 
(1998). Biofilm susceptibility to bacteriophage 
attack: the role of phage-borne polysaccharide 
depolymerase. Microbiology, 144:3039-3047. 
[18]. Farshadzadeh, Z., Taheri, B., Rahimi, S., Shoja, 
S., Pourhajibagher, M., Haghighi, M.A., Bahador, 
A. (2018). Growth Rate and Biofilm Formation 
Ability of Clinical and Laboratory-Evolved 
Colistin-Resistant Strains of Acinetobacter 
baumannii. Frontiers in Microbiology, 9:1-11, 
doi: 10.3389/fmicb.2018.00153. 
[19]. Feng, L., Li, X., Song, P., Du, G., Chen, J. (2014). 
Physicochemical properties and membrane 
biofouling of extra-cellular polysaccharide 
produced by a Micrococcus luteus strain. World 
Journal of Microbiology and Biotechnology, 
30:2025-2031. 
[20]. Mukamolova, G.V., Yanopolskaya, N.D., 
Votyakova, T.V., Popov, V.I., Kaprelyants, A.S., 
Kell, D.B. (1995). Biochemical changes 
accompanying the long-term starvation of 
Micrococcus luteus cells in spent growth medium. 
Archives of Microbiology, 163:373-379. 
[21]. Seifert, H., Kaltheuner, M., Perdreau-Remington, 
F. (1995). Micrococcus luteus Endocarditis: Case 
Report and Review of the Literature. Zentralblatt 
für Bakteriologie, 282:431-435. 
[22]. Peces, R., Gago, E., Tejada, F., Laures, A.S., 
Alvarez-Grande, J. (1997). Relapsing bacteraemia 
due to Micrococcus luteus in a haemodialysis 
patient with a Perm-Cath catheter. Nephrology 
Dialysis Transplantation, 12:2428-2429. 
[23]. Fosse, T., Peloux, Y., Granthil, C., Toga, B., 
Bertrando, J., Sethian, M. (1985). Meningitis Due 
to Micrococcus luteus. Infection, 13:280-281. 
[24]. Kaprelyants, A.S., Kell, D.B. (1993). Dormancy 
in Stationary-Phase Cultures of Micrococcus 
luteus: Flow Cytometric Analysis of Starvation 
and Resuscitation. Applied and Environmental 
Microbiology, 59(10):3187-3196. 
[25]. Mali, S., Mitchell, M., Havis, S., Bodunrin, A., 
Rangel, J., Olson, G., Widger, W.R., Bark, S.J. 
(2017). A Proteomic Signature of Dormancy in 
the Actinobacterium Micrococcus luteus. Journal 
of Bacteriology, 199(14):1-15. 
[26]. Kang, H.W., Kim, J.W., Jung, T.S., Woo, G.J. 
(2013). wksl3, a New Biocontrol Agent for 
Salmonella enterica Serovars Enteritidis and 
Typhimurium in Foods: Characterization, 
Isolation of phage for Pathogenic Bacteria            Hillis et al 
J Adv Lab Res Biol (E-ISSN: 0976-7614) - Volume 9│Issue 4│2018          Page | 94 
Application, Sequence Analysis, and Oral Acute 
Toxicity Study. Applied and Environmental 
Microbiology, 79(6):1956-1968. 
[27]. Li, L., Zhang, Z. (2014). Isolation and 
characterization of a virulent bacteriophage SPW 
specific for Staphylococcus aureus isolated from 
bovine mastitis of lactating dairy cattle. Molecular 
Biology Reports, 41:5829-5838. 
[28]. Shin, H., Lee, J.H., Kim, H., Choi, Y., Heu, S., 
Ryu, S. (2012). Receptor Diversity and Host 
Interaction of Bacteriophages Infecting 
Salmonella enterica Serovar Typhimurium. PLOS 
One, 7(8):1-11. 
[29]. Warner, C.M., Barker, N., Lee, S.W., Perkins, E.J. 
(2014). M13 bacteriophage production for large-
scale applications. Bioprocess Biosystems 
Engineering, 37(10):2067-2072. 
[30]. Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, 
S., Ujihara, T., Kuroda, M., Ikeuchi, M., Tani, T., 
Fujieda, M., Wakiguchi, H., Imai, S. (2005). 
Bacteriophage therapy: a revitalized therapy 
against bacterial infectious diseases. Journal of 
Infection and Chemotherapy, 11:211-219. 
[31]. Cady, K.C., Bondy-Denomy, J., Heussler, G.E., 
Davidson, A.R., O’Toole, G.A. (2012). The 
CRISPER/Cas Adaptive Immune System of 
Pseudomonas aeruginosa Mediates Resistance to 
naturally occurring and Engineered Phages. 
Journal of Bacteriology, 194(21):5728-5738. 
[32]. Ghajavand, H., Esfahani, B.N., Havaei, A., Fazeli, 
H., Jafari, R., Moghim, S. (2017). Isolation of 
bacteriophages against multidrug resistant 
Acinetobacter baumannii. Research in 
Pharmaceutical Sciences, 12(5):373-380. 
 
 
 
